Navigation Links
C&J Industries Completes Phases I and II of Building Expansion
Date:7/21/2011

MEADVILLE, Pa., July 21, 2011 /PRNewswire/ -- C&J Industries announced today the completion of Phases I and II of their $6 million plant expansion. With these 2 Phases complete, C&J now has three Class VIII clean rooms that house a total of 25 Injection Molding presses. These presses range in size from 20 Ton, .56 oz shot to 390 Ton, 37.5 oz shot. Twenty-four of the machines are Toshiba all-electric presses.

C&J has also opened a new and expanded QA Lab that is fully equipped to accommodate both new tooling and program development as well as on-going surveillance and monitoring of existing production.

Phase III of the building expansion will include the transfer of 17 presses from the General Molding Room to the soon-to-be-completed 12,000 sqft expansion. The new expansion will be a White Room that will house presses ranging in size from 55 Ton, 2 oz shot size to 720 Ton, 102 oz shot.

Phases IV and V of the building expansion and renovation will include converting the current contract manufacturing room into a White Assembly Room. The final phase of the project will include a Class VIII Medical Device Assembly Room. Updates on these additional phases of the project will be announced in the next 2-3 months.

C&J has positioned itself to rapidly handle any new plastic medical device or project. With the additional capability being brought online, C&J has increased its medical production capability by over 50 percent.

About C&J Industries: C&J Industries (http://www.cjindustries.com/) is a full-service pharmaceutical and medical contract manufacturing firm specializing in plastic product design and development, contract medical device assembly and medical injection molding components. In
'/>"/>

SOURCE C&J Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
2. Prix Galien USA Honors Innovation in Science and Biotech Industries
3. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
4. Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses
5. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
6. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest
7. Roper Industries Completes the Acquisition of Verathon, Inc.
8. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest and Conversion Rate Adjustment
9. SL Industries Names Louis J. Belardi Chief Financial Officer
10. Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science Industries
11. iGPS Announces iGPS bios™, a New Pallet Rental Service Designed Exclusively for the Pharmaceutical and Life Sciences Industries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, Inc., ... today that it will present new results on ... industry conference sponsored by the PML Consortium (composed ... JC polyomavirus (JCV) is the causative agent of ... kinase inhibitor in an extended release formulation, can ...
(Date:5/23/2013)... -- InspireMD, Inc. ("InspireMD" or the ... protection stents, today announced new 6-month results from ... trial demonstrating that the MGuard Embolic Protection Stent ... in all-cause mortality in ST segment elevation myocardial ... presented at the InspireMD STEMI Symposium at EuroPCR, ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Bionovo, Inc. (Nasdaq: BNVI, BNVID), a drug discovery and development ... oncology, today announced that Dr. Isaac Cohen, O.M.D., Chairman and ... Healthcare Conference at 4:00 p.m. ET on Tuesday, September 28, ... Palace hotel in New York City. Interested parties ...
... Sept. 21 Anthera Pharmaceuticals, Inc. (Nasdaq: ... definitive agreements with certain accredited investors in connection with ... Section 4(2) of the Securities Act of 1933, as ... of the transaction, Anthera will receive gross proceeds of ...
Cached Medicine Technology:Bionovo to Present at the JMP Securities Healthcare Conference 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 3Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 4
(Date:5/23/2013)... CT (PRWEB) May 23, 2013 Six ... a million dollars by Lyme Research Alliance, the nation's ... major academic institutions. The studies focus on the epidemiology of, ... diseases.  , “LRA is proud to support the ... and the brightest men and women in the field ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Elegance for a woman ... her flair, her taste, her intrigue can often be found in ... gateway to a woman's soul is through her eyes. It ... who she is! That is why the elegance of a woman ... . , Women today, more than any other time, utilize eyewear ...
(Date:5/23/2013)... Looking for tips on how to avoid ... of caring for your aging parent? Today the ... released the results of a survey of 335 geriatric care ... , Here are the top 5 tips identified by these ... survey respondents selecting each option): , 1.    Give each family member ...
(Date:5/23/2013)... Sika Sarnafil , the worldwide market leader ... Roof Systems of Iowa as the Recycling Project of ... during the re-roofing of the SuperTarget retail store in ... Elite contractor and one of Target’s Preferred Tier One ... sustainable building practices and they are a worthy recipient ...
(Date:5/23/2013)... According to a April 18, 2013 ... Found in Everyday Items Can Inhibit Fat Storage,” found ... as cosmetics and other products curb the storage of ... men and women who use such products experience accelerated ... wrinkles earlier than they otherwise would have (Go ...
Breaking Medicine News(10 mins):Health News:Six Investigators Awarded Lyme Research Alliance Grants 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 3Health News:Six Investigators Awarded Lyme Research Alliance Grants 4Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:New Survey of Aging Experts Gives Top 5 Tips for Avoiding Family Feud when Caring for Aging Parents 2Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2Health News:Aging and Wrinkles – Gold Found in Everyday Products Can Accelerate the Visual Signs of Aging 2
... a day after two minors died minutes after receiving ... district of Chhattisgarh. ,Two brothers, Umashanker, 6 years, ... they received injections for treatment of fever, cough and ... other members of the same family, who were also ...
... (also known as NRP104 or LDX) by Shire plc ... yielded a good response in children with Attention Deficit ... data was presented at a national meeting of child ... done on 269 children between 6 and 12 who ...
... from the University of California at Los Angeles (UCLA) ... resonance imaging (MRI) scan using the internet by an ... the remote scans were better in quality than the ... technology would benefit areas with inadequate staff members and ...
... farms with genetically modified papaya has led to suing ... called Greenpeace. ,Greenpeace is to take legal ... supply of genetically engineered papaya seeds to farmers throughout ... genetic engineering campaigner for Green Peace Southeast Asia, said, ...
... of harmful chemicals that may be present in some fish, ... ,Following the study of toxic substances in Puget Sound fish, ... Chinook salmon. ,Their study revealed that that Chinook ... mercury and PCBs, which is a banned industrial chemical. ...
... smoking cessation therapy used to help reduce adverse events ... of death for smokers admitted to// the intensive care ... 2006, the 72nd annual international scientific assembly of the ... smokers admitted to the ICU who received nicotine replacement ...
Cached Medicine News:Health News:Smoking Cessation Therapy May be Harmful for ICU Patients 2
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... coated with a thin layer ... the surface slick as glass ... prevent debris from collecting on ... For partial stenosis. Silicone with ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: